Navellier & Associates’s CME Group CME Stock Holding History

Navellier & Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16M	Buy	9,762 +253	+3%	+$70K	0.17%	123
2026 Q1	$2.81M	Sell	9,509 -489	-5%	-$145K	0.29%	83
2025 Q4	$2.73M	Sell	9,998 -925	-8%	-$251K	0.31%	79
2025 Q3	$2.95M	Buy	10,923 +156	+1%	+$42.4K	0.3%	87
2025 Q2	$2.97M	Sell	10,767 -8	-0.1%	-$2.18K	0.37%	78
2025 Q1	$3.04M	Buy	+10,775	New	+$2.66M	0.42%	64
2019 Q2	–	Sell	-16,880	Closed	-$2.78M	–	278
2019 Q1	$2.78M	Sell	16,880 -637	-4%	-$113K	0.43%	64
2018 Q4	$3.29M	Sell	17,517 -4,495	-20%	-$830K	0.56%	35
2018 Q3	$3.75M	Buy	22,012 +507	+2%	+$85.4K	0.49%	60
2018 Q2	$3.52M	Buy	+21,505	New	+$3.51M	0.49%	51

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Navellier & Associates's CME Position: Q2 2026 in Review

Navellier & Associates increased its CME Group (CME) stake by 2.7% in Q2 2026, buying an estimated $70K and bringing the position to 9,762 shares worth $2.16M. The position accounts for 0.17% of the portfolio, ranked #123.

Navellier & Associates first reported a position in CME in Q2 2018 and has held it in 10 quarters since. The position peaked at $3.75M in Q3 2018. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Navellier & Associates held 9,762 shares of CME Group worth $2.16M as of Q2 2026.
Navellier & Associates bought 253 CME Group shares in Q2 2026, an estimated $70K.
CME Group made up 0.17% of Navellier & Associates's portfolio in Q2 2026, its #123 holding.
Navellier & Associates first reported a position in CME Group in Q2 2018 and has held it in 10 quarters since.
Navellier & Associates's CME Group position peaked at $3.75M in Q3 2018.
1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.